Colgate-Palmolive (NYSE:CL) Shares Bought by DGS Capital Management LLC

DGS Capital Management LLC increased its holdings in Colgate-Palmolive (NYSE:CL) by 4.4% during the 4th quarter, Holdings Channel.com reports. The institutional investor owned 9,001 shares of the company’s stock after purchasing an additional 376 shares during the quarter. DGS Capital Management LLC’s holdings in Colgate-Palmolive were worth $818,000 at the end of the most recent reporting period.

Several other hedge funds have also recently added to or reduced their stakes in the business. D Orazio & Associates Inc. increased its stake in shares of Colgate-Palmolive by 3.9% during the 3rd quarter. D Orazio & Associates Inc. now owns 2,862 shares of the company’s stock worth $297,000 after purchasing an additional 108 shares in the last quarter. Fiducient Advisors LLC increased its position in Colgate-Palmolive by 5.2% during the third quarter. Fiducient Advisors LLC now owns 2,231 shares of the company’s stock worth $232,000 after buying an additional 110 shares in the last quarter. Sequoia Financial Advisors LLC raised its holdings in shares of Colgate-Palmolive by 0.6% in the third quarter. Sequoia Financial Advisors LLC now owns 20,392 shares of the company’s stock worth $2,117,000 after acquiring an additional 113 shares during the last quarter. Great Waters Wealth Management lifted its position in shares of Colgate-Palmolive by 1.5% in the third quarter. Great Waters Wealth Management now owns 7,669 shares of the company’s stock valued at $796,000 after acquiring an additional 117 shares in the last quarter. Finally, Waldron Private Wealth LLC boosted its stake in shares of Colgate-Palmolive by 2.1% during the third quarter. Waldron Private Wealth LLC now owns 5,632 shares of the company’s stock valued at $585,000 after acquiring an additional 118 shares during the last quarter. 80.41% of the stock is currently owned by hedge funds and other institutional investors.

Colgate-Palmolive Stock Performance

Shares of NYSE:CL opened at $87.88 on Friday. The company has a market cap of $71.79 billion, a P/E ratio of 25.18, a PEG ratio of 3.59 and a beta of 0.44. Colgate-Palmolive has a one year low of $80.03 and a one year high of $109.30. The business’s 50-day simple moving average is $91.93 and its 200 day simple moving average is $97.51. The company has a debt-to-equity ratio of 9.46, a quick ratio of 0.68 and a current ratio of 1.04.

Colgate-Palmolive Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Tuesday, January 21st will be issued a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a yield of 2.28%. The ex-dividend date is Tuesday, January 21st. Colgate-Palmolive’s payout ratio is 57.31%.

Insider Buying and Selling

In related news, CFO Stanley J. Sutula III sold 45,410 shares of the business’s stock in a transaction dated Tuesday, November 5th. The stock was sold at an average price of $94.11, for a total value of $4,273,535.10. Following the transaction, the chief financial officer now owns 36,726 shares in the company, valued at approximately $3,456,283.86. The trade was a 55.29 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. 0.34% of the stock is currently owned by insiders.

Analyst Upgrades and Downgrades

Several equities research analysts have issued reports on the stock. Wells Fargo & Company decreased their price target on shares of Colgate-Palmolive from $92.00 to $83.00 and set an “underweight” rating on the stock in a research note on Tuesday, January 7th. Piper Sandler lowered their target price on shares of Colgate-Palmolive from $121.00 to $112.00 and set an “overweight” rating for the company in a research note on Monday, January 6th. TD Cowen reduced their price target on Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating on the stock in a research note on Wednesday, January 8th. UBS Group dropped their target price on Colgate-Palmolive from $112.00 to $104.00 and set a “buy” rating for the company in a research note on Thursday, January 16th. Finally, Barclays decreased their price target on Colgate-Palmolive from $96.00 to $83.00 and set an “equal weight” rating on the stock in a research note on Friday, January 17th. One investment analyst has rated the stock with a sell rating, ten have assigned a hold rating and twelve have assigned a buy rating to the company’s stock. According to MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus price target of $101.11.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.